Scientists uncover a new approach for treating aggressive cancer

Researchers at the University of North Carolina at Chapel Hill and the UNC Lineberger Comprehensive Cancer Center have uncovered a new role of a chromatin-modulatory enzyme, termed EZH2, during cancer development. They then developed a new therapeutic approach with a potent small-molecule inhibitor of this enzyme. Gabrielle’s Angels supported this work with a grant to Dr. Greg Wang, co-lead author on this project, and we’re thrilled to see it lead to this important breakthrough!